Cover Image
市場調查報告書

分子診斷的歐洲市場 (各技術、各用途) - 產業分析、規模、佔有率、成長、趨勢、2015∼2023年的預測

Molecular Diagnostics Market (By Technology, By Application) - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

出版商 Transparency Market Research 商品編碼 354779
出版日期 內容資訊 英文 118 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
分子診斷的歐洲市場 (各技術、各用途) - 產業分析、規模、佔有率、成長、趨勢、2015∼2023年的預測 Molecular Diagnostics Market (By Technology, By Application) - Europe Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
出版日期: 2016年02月25日 內容資訊: 英文 118 Pages
簡介

本報告提供歐洲的分子診斷市場相關調查,市場現狀與今後的預測,各技術及各用途趨勢,各地區趨勢,及打入市場的主要企業簡介等彙整資料。

第1章 序論

第2章 摘要整理

第3章 歐洲的分子診斷市場:產業分析

  • 簡介
  • 促進要素
    • 歐洲的慢性及感染疾病的罹患率上升
    • 搭配診斷及個人化醫療的認識度提高
  • 阻礙要素
    • 償付政策相關問題
  • 機會
    • 技術的進步成為持續成長的機會
  • 波特五力分析
  • 市場魅力度分析
  • 市場魅力度分析:各地區
  • 市場魅力度分析:各技術
  • 市場魅力度分析:各用途
  • 患者群分析:各感染疾病
  • 患者群分析:各癌症
  • 患者群分析:各心血管疾病
  • 企業的市場佔有率
  • 競爭環境
  • 合併、收購

第4章 市場區隔:各技術

  • 簡介
  • 聚合酵素鏈鎖反應
  • 混合化
  • 質譜分析
  • 轉印媒介放大
  • 次世代定序
  • 生物晶片及微流體
  • 其他

第5章 市場區隔:各用途

  • 簡介
  • 癌症
  • 感染疾病
  • 病毒
  • 細菌學
  • 基因學
  • 血液檢驗
  • 婦產科
  • 微生物學
  • 產前及新生兒篩檢

第6章 歐洲的分子診斷市場:各地區分析

  • 北歐
  • 東歐
  • 西歐
  • 南歐
  • 其他

第7章 現狀及歷史概要

第8章 企業簡介

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Alere, Inc.
  • Affymetrix, Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Cepheid, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Meridian Bioscience, Inc.
  • PerkinElmer, Inc.
  • Randox Laboratories, Ltd.
  • QIAGEN N.V.
  • Siemens AG
  • Thermo Fisher Scientific, Inc.
目錄

This report on the molecular diagnostics market studies the current and future prospects of the market in Europe. Growing incidences of chronic infectious diseases such as tuberculosis, HIV/AIDS, diarrhea, pneumonia, in addition to increasing geriatric population, and rising number of biotechnology companies is expected to accentuate the growth of molecular diagnostics market in Europe. The Europe molecular diagnostics market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the Europe molecular diagnostics market with respect to market segments based on technology, application and their geographic analysis.

Based on technology, the molecular diagnostics market in Europe has been segmented into seven major categories: polymerase chain reaction, hybridization (ISH AND FISH), mass spectrometry, transcription mediated amplification (TMA), next generation sequencing, biochips and microfluidics, others which includes nanotechnology and proteomics. Likewise, on the basis of application, the Europe molecular diagnostics market has been segmented into oncology, infectious disease testing, genomics, blood screening, women's health, microbiology, and prenatal and newborn screening. Infectious disease testing has been segmented into two major categories, namely, virology and bacteriology. Virology segment includes human immunodeficiency virus (HIV) testing, human parainfluenza virus (1, 2, 3, 4) testing, human respiratory syncytial virus (A, B) testing, human papillomavirus (HPV) testing, human rhinovirus A/B testing, hepatitis C virus (HCV) testing, and others which includes human adenovirus (A/B/C/D/E), influenza (A, B), etc. Bacteriology includes hospital acquired infection (HAI) testing, chlamydophila pneumonia testing, chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) testing, staphylococcus aureus testing (MRSA), and others which includes haemophilus influenza, mycoplasma pneumonia, etc. The market segments have been extensively analyzed based on usefulness, adoption, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2013 to 2023. The molecular diagnostics market report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year. A brief patient pool analysis by infectious disease, cancer and cardiovascular disease have also been discussed in the Europe molecular diagnostics report.

Geographically, the molecular diagnostics market in Europe has been categorized into five major regions: Northern Europe, Eastern Europe, Western Europe, Southern Europe, and Rest of Europe. The market size and forecast for each of these regions has been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter's Five Forces analysis, ADL matrix, growth share matrix, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the Europe molecular diagnostics market.

Current and future trends has also been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the Europe molecular diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, QIAGEN N.V., Hologic, Inc., Cepheid, Inc., Siemens AG, Alere. Inc., BioMerieux, Bio-Rad Laboratories, PerkinElmer, Inc., Thermo Fisher Scientific, Inc., and others.

The Europe molecular diagnostics market is segmented as given below:

Europe Molecular Diagnostics Market, by Technology

  • Polymerase Chain Reaction
  • Hybridization (ISH and FISH)
  • Mass Spectrometry
  • Transcription Mediated Amplification (TMA)
  • Next Generation Sequencing
  • Biochips and Microfluidics
  • Others (Nanotechnology and Proteomic)

Europe Molecular Diagnostics Market, by Application

  • Oncology
  • Infectious Disease Testing
  • Genomics
  • Blood Screening
  • Women's Health
  • Microbiology
  • Prenatal and Newborn Screening

Europe Molecular Diagnostics Drugs Market, by Major Region and Countries

  • Northern Europe
    • Ireland
    • Norway
    • Sweden
    • United Kingdom
    • Rest of Northern Europe (Denmark, Finland)
  • Eastern Europe
    • Ukraine
    • Poland
    • Czech Republic
    • Russia
    • Rest of Eastern Europe (Hungary, Romania)
  • Western Europe
    • France
    • Germany
    • Austria
    • Rest of Western Europe (Netherlands, Belgium)
  • Southern Europe
    • Italy
    • Spain
    • Portugal
    • Rest of Southern Europe (Greece, Switzerland)
  • Rest of Europe

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

  • 2.1. Europe Molecular Diagnostics Market Revenue, 2013-2023 (US$ Mn)
  • 2.2. Europe Molecular Diagnostics Market, by Technology, 2014 (US$ Mn)
  • 2.3. Europe Molecular Diagnostics Market, by Application, 2014 (US$ Mn)
  • 2.4. Europe Market Share by Major Region, 2014 and 2023 (Value %)
  • 2.5. Europe Molecular Diagnostics Market Snapshot

3. Europe Molecular Diagnostics Market - Industry Analysis

  • 3.1. Introduction
  • 3.2. Drivers
    • 3.2.1. Rising prevalence of chronic and infectious diseases in Europe
    • 3.2.2. Increasing awareness and acceptance of companion diagnostics and personalized medicines
  • 3.3. Restraints
    • 3.3.1. Issues with reimbursement policies
  • 3.4. Opportunities
    • 3.4.1. Technological advancement to offer sustained growth opportunities
  • 3.5. Porter's Five Forces Analysis: Europe Molecular Diagnostics Market
  • 3.6. Market Attractiveness Analysis - Europe Molecular Diagnostics Market, By Region
  • 3.7. Market Attractiveness Analysis - Europe Molecular Diagnostics Market, By Technology
  • 3.8. Market Attractiveness Analysis - Europe Molecular Diagnostics Market, By Application
  • 3.9. Patient Pool Analysis, by Infectious Diseases
  • 3.10. Patient Pool Analysis, by Cancer
  • 3.11. Patient Pool Analysis, by Cardiovascular Diseases
  • 3.12. Company Market Share, Europe Molecular Diagnostics Market, By Key Players (2014) (%)
  • 3.13. Competitive Landscape
    • 3.13.1. ADL Matrix Analysis, 2014, by Top 3 Market Players
    • 3.13.2. Brand Positioning Map, by Top 5 Market Players
    • 3.13.3. Business Performance Analysis: F. Hoffmann-La Roche AG
    • 3.13.4. Business Performance Analysis: Abbott Laboratories
    • 3.13.5. Business Performance Analysis: QIAGEN
    • 3.13.6. End-user Analysis (Growth Share Matrix)
  • 3.14. Mergers & Acquisitions

4. Market Segmentation - By Technology

  • 4.1. Introduction
  • 4.2. Europe Polymerase Chain Reaction in Molecular Diagnostics Market, 2013-2023 (US$ Mn)
  • 4.3. Europe Hybridization (ISH and FISH) in Molecular Diagnostics Market, 2013-2023 (US$ Mn)
  • 4.4. Europe Mass Spectrometry in Molecular Diagnostics Market, 2013-2023 (US$ Mn)
  • 4.5. Europe Transcription Mediated Amplification (TMA) in Molecular Diagnostics Market, 2013-2023 (US$ Mn)
  • 4.6. Europe Next Generation Sequencing in Molecular Diagnostics Market, 2013-2023 (US$ Mn)
  • 4.7. Europe Biochips and Microfluidics in Molecular Diagnostics Market, 2013-2023 (US$ Mn)
  • 4.8. Europe Other Technologies in Molecular Diagnostics Market, 2013-2023 (US$ Mn)

5. Market Segmentation - By Application

  • 5.1. Introduction
  • 5.2. Europe Molecular Diagnostics Market for Oncology, 2013-2023 (US$ Mn)
  • 5.3. Europe Molecular Diagnostics Market for Infectious Disease Testing, 2013-2023 (US$ Mn)
    • 5.3.1. Europe Molecular Diagnostics Market for Virology, 2013-2023 (US$ Mn)
    • 5.3.2. Europe Molecular Diagnostics Market for Bacteriology, 2013-2023 (US$ Mn)
  • 5.4. Europe Molecular Diagnostics Market for Genomics, 2013-2023 (US$ Mn)
  • 5.5. Europe Molecular Diagnostics Market for Blood Screening, 2013-2023 (US$ Mn)
  • 5.6. Europe Molecular Diagnostics Market for Women's Health, 2013-2023 (US$ Mn)
  • 5.7. Europe Molecular Diagnostics Market for Microbiology, 2013-2023 (US$ Mn)
  • 5.8. Europe Molecular Diagnostics Market for Prenatal and Newborn Screening, 2013-2023 (US$ Mn)

6. Europe Molecular Diagnostics Market - Regional Analysis

  • 6.1. Northern Europe Molecular Diagnostics Market, 2013-2023 (US$ Mn)
  • 6.2. Eastern Europe Molecular Diagnostics Market, 2013-2023 (US$ Mn)
  • 6.3. Western Europe Molecular Diagnostics Market, 2013-2023 (US$ Mn)
  • 6.4. Southern Europe Molecular Diagnostics Market, 2013-2023 (US$ Mn)
  • 6.5. Rest of Europe Molecular Diagnostics Market, 2013-2023 (US$ Mn)

7. Current Trend and Historical Snapshot

8. Company Profiles

  • 8.1. Abbott Laboratories
  • 8.2. Agilent Technologies, Inc.
  • 8.3. Alere, Inc.
  • 8.4. Affymetrix, Inc.
  • 8.5. bioMérieux SA
  • 8.6. Bio-Rad Laboratories, Inc.
  • 8.7. Cepheid, Inc.
  • 8.8. Danaher Corporation
  • 8.9. F. Hoffmann-La Roche Ltd.
  • 8.10. Hologic, Inc.
  • 8.11. Meridian Bioscience, Inc.
  • 8.12. PerkinElmer, Inc.
  • 8.13. Randox Laboratories, Ltd.
  • 8.14. QIAGEN N.V.
  • 8.15. Siemens AG
  • 8.16. Thermo Fisher Scientific, Inc.
Back to Top